# Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114

> **NCT00296257** · PHASE2 · TERMINATED · sponsor: **Dainippon Sumitomo Pharma Europe LTd.** · enrollment: 312 (actual)

## Conditions studied

- Rheumatoid Arthritis (RA)

## Interventions

- **DRUG:** SMP-114

## Key facts

- **NCT ID:** NCT00296257
- **Lead sponsor:** Dainippon Sumitomo Pharma Europe LTd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-02
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** 312 (ACTUAL)
- **Last updated:** 2009-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296257, "Assessment of Safety, Pharmacokinetics and Efficacy in a Combination Treatment With SMP-114". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00296257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*